Racial Differences Persist in Cause-specific Mortality in Breast Cancer

Share this content:
While breast cancer-specific mortality among older women has improved across all races in recent years, other cause-mortality has not.
While breast cancer-specific mortality among older women has improved across all races in recent years, other cause-mortality has not.

While breast cancer-specific mortality among older women has improved across all races in recent years, other cause-mortality has not, according to a study published online ahead of print in the Annals of Oncology.

Yu Shen, PhD, and fellow researchers from The University of Texas MD Anderson Cancer Center looked at SEER-Medicare linked data to identify women who were at least 66 years and were diagnosed with stage 4 breast cancer between 2002 to 2009.

Estimating for mortality trends using the Kaplan-Meier method, they wanted to use contemporary population data to study factors associated with overall, breast cancer-specific, and other cause-mortality.

They found that median overall survival time for non-Hispanic blacks had improved from 8.6 months in 2002 to 2003 to 9.9 months in 2007 to 2009, compared to 12.1 months to 14.8 months among non-Hispanic whites in the same time period.

RELATED: No Association Found Between Opioid Use, Breast Cancer Recurrence

Upon multivariate analyses, they also found that risk of breast cancer-specific mortality was significantly lower among patients diagnosed in 2007 to 2009 while other cause-mortality showed little change, compared to risk found in patients diagnosed from 2002 to 2003. Additionally, non-Hispanic blacks were found to have a higher risk of both mortality types compared to non-Hispanic whites.

“Efforts should be devoted to improving other cause mortality for all women, with special attention toward decreasing breast cancer mortality for non-Hispanic black women,” the authors concluded.

Reference

  1. Ning J, Peng S, Ueno N, et al. Has racial difference in cause-specific death improved in older patients with late-stage breast cancer?. Ann Oncol. [epub ahead of print]. 2015. doi: 10.1093/annonc/mdv330. July 28, 2015.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters